Intrinsiqq
Immunovant Inc. logo

Immunovant Inc. Quality Score

IMVT

Compare

Could not load quality data

This may be a temporary issue. If it persists, the ticker may not be covered yet.

SourceQuality score computed from the 10-Q filed 3 Nov 2026, covering the period ending 30 Sept 2026, as reported to the SEC. Data last refreshed 9 Nov 2026. How this is calculated.

Fiscal year ends Mar. Sector medians are approximate S&P 500 benchmarks and update periodically. Checks use broad-market heuristics, so sector norms may differ, and the valuation checks are more cyclical than the quality checks.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with IMVT

CompareIntrinsic value
CELZCreative Medical Technology Holdings Inc.
$0.40-8.14%10
VCELVericel Corporation
$57.52-1.27%65
IOVAIovance Biotherapeutics, Inc.
$6.90-5.61%10
CGONCG Oncology, Inc.
$79.47-2.97%40
TECHBio-Techne Corporation
$72.67-0.04%41
MRNAModerna, Inc.
$195.00-2.17%13
HALOHalozyme Therapeutics Inc.
$91.35-1.82%70
SCLXScilex Holding Company
$0.57-12.95%0

Held by ETFs

IMVT is in 51 US ETFs. The largest of them, with IMVT's weight in each:

Spot a number that looks wrong? Check it in IMVT's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing IMVT

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.